全文获取类型
收费全文 | 4240篇 |
免费 | 454篇 |
出版年
2022年 | 33篇 |
2021年 | 87篇 |
2020年 | 46篇 |
2019年 | 52篇 |
2018年 | 60篇 |
2017年 | 52篇 |
2016年 | 100篇 |
2015年 | 160篇 |
2014年 | 182篇 |
2013年 | 180篇 |
2012年 | 267篇 |
2011年 | 222篇 |
2010年 | 131篇 |
2009年 | 130篇 |
2008年 | 178篇 |
2007年 | 185篇 |
2006年 | 143篇 |
2005年 | 136篇 |
2004年 | 148篇 |
2003年 | 152篇 |
2002年 | 141篇 |
2001年 | 100篇 |
2000年 | 100篇 |
1999年 | 81篇 |
1998年 | 47篇 |
1997年 | 34篇 |
1996年 | 31篇 |
1995年 | 41篇 |
1994年 | 35篇 |
1993年 | 53篇 |
1992年 | 83篇 |
1991年 | 74篇 |
1990年 | 68篇 |
1989年 | 69篇 |
1988年 | 67篇 |
1987年 | 62篇 |
1986年 | 40篇 |
1985年 | 50篇 |
1984年 | 64篇 |
1983年 | 49篇 |
1982年 | 35篇 |
1980年 | 44篇 |
1979年 | 43篇 |
1978年 | 47篇 |
1977年 | 40篇 |
1976年 | 50篇 |
1975年 | 44篇 |
1974年 | 39篇 |
1973年 | 46篇 |
1972年 | 31篇 |
排序方式: 共有4694条查询结果,搜索用时 15 毫秒
1.
Mutant alpha-synuclein-induced degeneration is reduced by parkin in a fly model of Parkinson's disease. 总被引:2,自引:0,他引:2
Parkinson's disease (PD) patients show a characteristic loss of motor control caused by the degeneration of dopaminergic neurons. Mutations in the genes that encode alpha-synuclein and parkin have been linked to inherited forms of this disease. The parkin protein functions as a ubiquitin ligase that targets proteins for degradation. Expression of isoforms of human alpha-synuclein in the Drosophila melanogaster nervous system forms the basis of an excellent genetic model that recapitulates phenotypic and behavioural features of PD. Using this model, we analysed the effect of parkin co-expression on the climbing ability of aging flies, their life span, and their retinal degeneration. We have determined that co-expression of parkin can suppress phenotypes caused by expression of mutant alpha-synuclein. In the developing eye, parkin reduces retinal degeneration. When co-expressed in the dopaminergic neurons, the ability to climb is extended over time. If conserved in humans, we suggest that upregulation of parkin may prove a method of suppression for PD induced by mutant forms of alpha-synuclein. 相似文献
2.
F. F. Snyder A. E. Chudley P. M. MacLeod R. J. Carter E. Fung J. K. Lowe 《Human genetics》1984,67(1):18-22
Summary A family is described in which four affected males, spanning two generations, have hyperuricemia and gout accompanied by hematuria but are without severe neurologic involvement. The affected males were found to have markedly reduced levels of erythrocytic hypoxanthine-guanine phosphoribosyltransferase (HGPRT) activity; these were 5–12% with hypoxanthine and 0.5–3% with guanine as compared to controls. Erythrocytic adenine phosphoribosyltransferase (APRT) was approximately three-fold elevated in the affected individuals.The residual HGPRT activity in affected males enabled characterization of some of the properties of this mutation. The apparent Michaelis constants (km) for both hypoxanthine and guanine were essentially unchanged, whereas the km for PP-ribose-P was approximately 10–20-fold elevated for all four affected males. The enzyme was more sensitive to product inhibition by IMP and GMP than controls, and exhibited greater thermal lability at 65°C than found with control lysates. 相似文献
3.
4.
5.
Ellis, M. B. , Dematiaceous Hyphomycetes. Microbes and Biological Productivity , D. E. HUGHES and A. H. ROSE (Eds.) 相似文献
6.
7.
A spectroscopic analysis of the thermally induced folding-unfolding transition of beta-trypsin. 下载免费PDF全文
Absorption and fluorescence changes were used to monitor the thermally induced folding-unfolding transition of beta-trypsin. These parameters reflect changes in the microenvironment of different subsets of the four tryptophanyl residues of this protein. The thermal transition was found to be sequential. 相似文献
8.
The isolation of mutants of Saccharomyces cerevisiae that divide at approximately half the size of the wild type is described. Three mutants have been isolated in which the small size at bud initiation is due to a mutation in a single nuclear gene. 相似文献
9.
10.
Jonas G. Barlind Linda K. Buckett Sharon G. Crosby Öjvind Davidsson Hans Emtenäs Anne Ertan Ulrik Jurva Malin Lemurell Pablo Morentin Gutierrez Karolina Nilsson Gavin O’Mahony Annika U. Petersson Alma Redzic Fredrik Wågberg Zhong-Qing Yuan 《Bioorganic & medicinal chemistry letters》2013,23(9):2721-2726
[Acyl CoA]monoacylglycerol acyltransferase 2 (MGAT2) is of interest as a target for therapeutic treatment of diabetes, obesity and other diseases which together constitute the metabolic syndrome. In this Letter we report our discovery and optimisation of a novel series of MGAT2 inhibitors. The development of the SAR of the series and a detailed discussion around some key parameters monitored and addressed during the lead generation phase will be given. The in vivo results from an oral lipid tolerance test (OLTT) using the MGAT2 inhibitor (S)-10, shows a significant reduction (68% inhibition relative to na?ve, p <0.01) in plasma triacylglycerol (TAG) concentration. 相似文献